Search results for " Second"

showing 10 items of 1396 documents

Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis

2022

PURPOSE: To describe data on epidemiology, microbiology, clinical characteristics and outcome of adult patients admitted in the intensive care unit (ICU) with secondary peritonitis, with special emphasis on antimicrobial therapy and source control. METHODS: Post hoc analysis of a multicenter observational study (Abdominal Sepsis Study, AbSeS) including 2621 adult ICU patients with intra-abdominal infection in 306 ICUs from 42 countries. Time-till-source control intervention was calculated as from time of diagnosis and classified into 'emergency' ( 6 h). Relationships were assessed by logistic regression analysis and reported as odds ratios (OR) and 95% confidence interval (CI). RESULTS: The…

AdultSecondary peritonitiCritical IllnessPeritonitisCritical Care and Intensive Care MedicineAnti-Bacterial AgentsAntimicrobial therapyIntensive Care UnitsSecondary peritonitisIntra-abdominal infectionAnti-Infective AgentsRisk FactorsSource controlSepsisMedicine and Health SciencesHumansIntraabdominal InfectionsMortalityRetrospective StudiesAntimicrobial therapy; Intra-abdominal infection; Mortality; Secondary peritonitis; Source controlIntensive Care Medicine
researchProduct

The 2014 lifetime immunization schedule approved by the Italian scientific societies. Italian Society of Hygiene, Preventive Medicine, and Public Hea…

2014

AdultSecondaryAdolescentAdolescent; Adult; Age Factors; Aged; Child; Child Preschool; Humans; Immunization Secondary; Infant; Infant Newborn; Italy; Middle Aged; Societies Medical; Vaccination; Vaccines; Young Adult; Immunization ScheduleImmunization SecondaryYoung AdultMedicalHumansAge FactorPreschoolChildImmunization ScheduleSocieties MedicalAgedVaccinesVaccinationAge FactorsInfant NewbornInfantMiddle AgedNewbornSettore MED/38ItalyChild PreschoolImmunizationSocietiesVaccineHuman
researchProduct

Pneumococcus infections: Is the burden still as heavy?

2012

EA MERS CT3 Enjeu 3; International audience; The death rate of invasive pneumococcal infections decreased by 100 fold in one century. This tremendous improvement was due mainly to antibiotic use and multiple attempts at antipneumococcal vaccinations; thus, this was true only for developed countries. However, in France, the incidence has increased, over the last 10 years, in all age classes except for children vaccinated by the heptavalent pneumococcal conjugate vaccine. The incidence of these infections remains high, when associated to some risk factors such as HIV infection, malignant blood diseases, solid cancers, bronchial diseases, or alcohol abuse. The pneumococcal vaccine should be pr…

AdultSerotypeHeptavalent Pneumococcal Conjugate Vaccine[SDV]Life Sciences [q-bio]Immunization SecondaryAlcohol abuseGlobal HealthPneumococcal InfectionsPneumococcal Vaccines03 medical and health sciences0302 clinical medicineRisk FactorsHeptavalent Pneumococcal Conjugate Vaccine[SDV.BV]Life Sciences [q-bio]/Vegetal BiologyHumansMedicineserotype030212 general & internal medicineSerotypingChildinfection invasive à pneumocoque0303 health sciences030306 microbiologybusiness.industrypneumococcal invasive infectionDeveloped CountriesIncidenceMortality rateIncidence (epidemiology)VaccinationAge Factorssérotypemedicine.disease3. Good healthVaccinationPneumococcal infectionsStreptococcus pneumoniaeInfectious DiseasesPneumococcal vaccine[SDE]Environmental SciencesImmunologyDisease SusceptibilityFrancebusinessMédecine et Maladies Infectieuses
researchProduct

Anti-diphtheria antibody seroprotection rates are similar 10 years after vaccination with dTpa or DTPa using a mathematical model

2003

The reduced antigen content diphtheria, tetanus and pertussis (dTpa) vaccine (Boostrixtrade mark) has been shown to induce a strong booster response to all the vaccine components in 4-6 year olds. However, anti-diphtheria antibody levels were observed to be lower when compared to the "full strength" paediatric DTPa vaccine. To assess the impact of this difference on long-term protection, a mathematical model was developed to predict diphtheria antibody decay over time. The model was based on a linear decrease in log-transformed antibody concentrations after the first year post-vaccination. When applied to data collected 3.5 years after vaccination of 4-6 year olds with either DTPa or dTpa, …

AdultTime Factorsanimal diseasesImmunization SecondaryModels Biologicalcomplex mixturesCohort StudiesAntigenmedicineHumansChildDiphtheria-Tetanus-Pertussis VaccineImmunization ScheduleRandomized Controlled Trials as TopicBooster (rocketry)General VeterinaryGeneral Immunology and MicrobiologybiologyTetanusbusiness.industryDiphtheriaVaccinationPublic Health Environmental and Occupational HealthDiphtheriarespiratory systemmedicine.diseaseAntibodies BacterialVaccinationInfectious DiseasesImmunizationChild PreschoolImmunologycardiovascular systembiology.proteinMolecular MedicineAntibodybusinessDiphtheria antibodycirculatory and respiratory physiologyVaccine
researchProduct

Maternal coffee drinking in pregnancy and risk of small for gestational age birth

2005

Objective: We have analysed the association between coffee drinking before and during the three trimesters of pregnancy and risk of small for gestational age (SGA) birth. Methods: Cases were 555 women who delivered SGA births (ie <10th percentile according Italian standard). The controls included 1966 women who gave birth at term (≥37 weeks of gestation) to healthy infants of normal weight. Results: In comparison with nondrinkers, the ORs for SGA birth were 1.3 (95% confidence interval, CI, 0.9–1.9) for consumption of four or more cups of coffee/day before pregnancy, and 1.2 (95% CI 0.8–1.8), 1.2 (95% CI 0.8–1.8) and 0.9 (95% CI 0.6–1.4) for consumption of three or more cups of coffee/day d…

Adultmedicine.medical_specialtyAdolescentEpidemiologyPregnancy Trimester ThirdMedicine (miscellaneous)CoffeeRisk FactorsPregnancyEpidemiologyOdds RatioHumansMedicineRisk factorPregnancyNutrition and DieteticsDose-Response Relationship Drugbusiness.industryObstetricsRisk FactorConfoundingInfant NewbornPregnancy Outcomemedicine.diseaseConfidence intervalDietSmall for gestational age birthPregnancy Trimester FirstCase-Control StudiesPregnancy Trimester SecondInfant Small for Gestational AgeGestationSmall for gestational ageTerm BirthDiet; Epidemiology; Small for gestational age birthFemaleCase-Control StudiebusinessHumanFood Science
researchProduct

Mean maternal second-trimester hemoglobin concentration and outcome of pregnancy: a population-based study.

2008

Both anemia and the lack of physiological maternal plasma volume expansion during the second trimester are associated with higher maternal morbidity and poor fetal outcome. Mean hemoglobin levels between the 14th and 30th gestational weeks were calculated in 4985 consecutive pregnant women and were correlated with outcome data of pregnancy. It was found that 9.4% of participants (n = 3959) had normal pregnancy outcome. Mean maternal hemoglobin levels were significantly lower in women with a normal pregnancy (11.96 ± 0.94 g/dL) compared with women who had adverse outcome events (preeclampsia, n = 423, 12.5 ± 1.0 g/dL, P &lt; .0001; early birth, n = 464, 12.2 ± 1.01 g/dL, P &lt; .0001; low b…

Adultmedicine.medical_specialtyAnemiaPopulationMothersPreeclampsiaHemoglobinsPregnancymedicineHumansRisk factoreducationGynecologyeducation.field_of_studyPregnancybusiness.industryPregnancy OutcomeHematologyGeneral MedicineOdds ratiomedicine.diseaseConfidence intervalPregnancy ComplicationsLow birth weightPregnancy Trimester SecondWomen's HealthFemalemedicine.symptombusinessClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
researchProduct

The Cohort of Long-term Survivors at the German Childhood Cancer Registry

2008

Background With the increasing number of long-term survivors among patients diagnosed with cancer during childhood, questions concerning late effects have become a major research topic. To ascertain late effects, it is necessary to contact former patients. An essential requirement for such studies is a long-term surveillance (LTS) of former childhood cancer patients in their adolescence and their adulthood. The paper describes the role of the German Childhood Cancer Registry (GCCR) in LTS. A cohort of long-term survivors has been built up over the years. The characteristics of this LTS cohort and strategies for further improvement of LTS will be presented. Patients and methods Since 1980 th…

Adultmedicine.medical_specialtyPediatricsAdolescentLymphomaPopulationCohort StudiesYoung AdultQuality of lifeNeoplasmsEpidemiologymedicineHumansRegistriesSurvivorsYoung adultChildeducationChildhood Cancer Registryeducation.field_of_studyLeukemiaBrain Neoplasmsbusiness.industryNeoplasms Second PrimaryCancer registryChild PreschoolPediatrics Perinatology and Child HealthCohortlipids (amino acids peptides and proteins)businessFollow-Up StudiesCohort studyKlinische Pädiatrie
researchProduct

The negative predictive value of cervical interleukin-6 for the risk assessment of preterm birth.

2013

To determine the potential clinical use of cervical interleukin-6 (IL-6) as a negative predictor of preterm birth in symptomatic women.Observational prospective study carried out in a tertiary hospital.We studied 100 singleton pregnant women with threatened preterm delivery and intact membranes, between 24 and 34 weeks, recruited during the period 2006-2008. A cervical swab for IL-6 detection was taken and a transvaginal ultrasound scan was performed for measuring the cervical length.Five women delivered within 2 d and six women within 7 d. A high cervical IL-6 concentration was found in these women. The area under the ROC curve for cervical IL-6 was 0.97 for deliveries within 2 d after the…

Adultmedicine.medical_specialtyPregnancy Trimester ThirdRisk AssessmentYoung AdultPredictive Value of TestsPregnancymedicinePrevalenceHumansFalse Positive ReactionsProspective cohort studyPreterm deliveryGynecologyTransvaginal ultrasound scanbusiness.industryObstetricsInterleukin-6Infant NewbornObstetrics and GynecologyIntact membranesPredictive valuePregnancy Trimester SecondPediatrics Perinatology and Child HealthCervix MucusPremature BirthObservational studyFemaleRisk assessmentbusinessArea under the roc curveThe journal of maternal-fetalneonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
researchProduct

Laparoscopic pelvic lymphadenectomy in 32 pregnant patients with cervical cancer: Rationale, description of the technique, and outcome

2014

ObjectiveIndividualized treatment of pregnant patients with cervical cancer is mandatory; hence, information on nodal status is pivotal to allow a waiting strategy in early-stage disease.We aimed to verify the oncological safety and surgical reproducibility of a standardized laparoscopic pelvic lymphadenectomy in pregnant patients with cervical cancer.MethodsWe standardized laparoscopic pelvic lymphadenectomy during the first and second term of gestation in 32 patients with cervical cancer since 1999. According to gestational week (GW) of less than 16 GWs or more than 16 GWs, 2 different techniques were used.ResultsThe International Federation of Gynecology and Obstetrics stages were IA in …

Adultmedicine.medical_specialtyUterine Cervical NeoplasmStagingPelvimedicine.medical_treatmentUterine Cervical NeoplasmsPelvisObstetrics and gynaecologyPregnancyLaparotomymedicineHumansLaparoscopyLymph nodePelvisNeoplasm StagingCervical cancerPregnancymedicine.diagnostic_testbusiness.industryLymph NodeObstetrics and GynecologyLymphadenectomymedicine.diseaseSurgeryPregnancy Trimester Firstmedicine.anatomical_structureOncologyPregnancy Trimester SecondCervical cancerLymph Node ExcisionLymphadenectomyLaparoscopyFemaleLymph NodesbusinessPregnancy Complications NeoplasticHuman
researchProduct

Pharmacological interventions for somatoform disorders in adults

2014

BACKGROUND: Somatoform disorders are characterised by chronic, medically unexplained physical symptoms (MUPS). Although different medications are part of treatment routines for people with somatoform disorders in clinics and private practices, there exists no systematic review or meta-analysis on the efficacy and tolerability of these medications. We aimed to synthesise to improve optimal treatment decisions.OBJECTIVES: To assess the effects of pharmacological interventions for somatoform disorders (specifically somatisation disorder, undifferentiated somatoform disorder, somatoform autonomic dysfunction, and pain disorder) in adults.SEARCH METHODS: We searched the Cochrane Depression, Anxi…

Adultmedicine.medical_specialtylow-quality evidencemedicine.medical_treatmentPsychiatry and PsychologyAntidepressive Agents TricyclicCochrane LibraryPlaceboInternal medicineMedicine and Health SciencesmedicineHumansPharmacology (medical)somatoform disorderSomatoform DisordersAntipsychoticPsychiatryinterventionRandomized Controlled Trials as TopicPain disorderMedically unexplained physical symptomsbusiness.industrytrialsMiddle Agedmedicine.diseaseClinical trialPsychological Phenomena and ProcessesTolerabilityMeta-analysisAntidepressive Agents Second-GenerationbusinessSelective Serotonin Reuptake InhibitorsAntipsychotic AgentsCochrane Database of Systematic Reviews
researchProduct